Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 24,873 | 14,953 | 15,465 | 14,105 | 16,812 |
| Gross Profit | 24,873 | 14,953 | 15,465 | 14,105 | 16,812 |
| Operating Expenses | 127,195 | 48,387 | 27,617 | 27,050 | 27,505 |
| Operating Income | -102,322 | -33,434 | -12,152 | -12,945 | -10,694 |
| Other Income | 25,016 | -5,403 | -1,911 | 42,556 | 610 |
| Pre-tax Income | -77,306 | -38,837 | -14,063 | 29,611 | -10,084 |
| Income Tax | -16,185 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -61,121 | -38,837 | -14,063 | 29,611 | -10,084 |
| Net Income | $-61,121 | $-38,837 | $-14,063 | $29,611 | $-10,084 |
| EPS Basic Total Ops | -1.34 | -1.80 | -0.92 | 2.16 | -0.89 |
| EPS Basic Continuous Ops | -1.34 | -1.80 | -0.92 | 2.16 | -0.89 |
| EPS Diluted Total Ops | -1.34 | -1.80 | -0.92 | 2.07 | -0.89 |
| EPS Diluted Continuous Ops | -1.34 | -1.80 | -0.92 | 2.07 | -0.89 |
| EBITDA(a) | $-62,726 | $-32,905 | $-11,539 | $-12,079 | $-9,707 |